Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids

Kadi Lõhmussaar; Oded Kopper; Jeroen Korving; Harry Begthel; Celien P.H. Vreuls; Johan H. van Es; Hans Clevers

doi:10.1038/s41467-020-16432-0

Related publications

Article2017

The Potential of Targeting Ribosome Biogenesis in High-Grade Serous Ovarian Cancer

Shunfei Yan, Daniel Frank, Jinbae Son, Katherine M. Hannan, Ross D. Hannan, Keefe T. Chan, Richard B. Pearson, Elaine Sanij

Article2024

The Prognostic Role of BRD4 Expression in High-Grade Serous Ovarian Cancer

Αngeliki Andrikopoulou, Garyfalia Bletsa, Angeliki Rouvalis, D. Tsakogiannis, Maria Kaparelou, Alkistis Papatheodoridi, Dimitrios Haidopoulos, Michalis Liontos, Meletios A Dimopoulos, Flora Zagouri

Article2025

Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancer

Carmelo Cerra, Madeleine R. C. Tancock, Niko Thio, Ada Koo, Adrian Wong, Karla J. Cowley, Swati Varshney, Madelynne O. Willis, Kaylene J. Simpson, David D.L. Bowtell, Elaine Sanij, Elizabeth L. Christie, Richard B. Pearson, Jian Jian Kang, Keefe T. Chan

Article2021

Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting

Michalis Liontos, Alkistis Papatheodoridi, Αngeliki Andrikopoulou, Nikolaos Thomakos, Dimitrios Haidopoulos, Alexandros Rodolakis, Flora Zagouri, Aristotelis Bamias, Meletios A Dimopoulos

Article2025

Clinical validation of different HRD assays in high-grade serous ovarian cancer in Greek population.

Αngeliki Andrikopoulou, Anna Svarna, Ionas Papassotiriou, Αριστέα-Μαρία Παπανώτα, Alkistis Papatheodoridi, Eleni Zografos, Athanasios Michas, N Dedes, Maria Kaparelou, Flora Zagouri, Meletios A Dimopoulos, Michalis Liontos